Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-intensity Atorvastatin for Arteriovenous Fistula Failure
NCT03188978Phase 2Withdrawn
- Sponsor
- Albany Medical College
- Start
- Nov 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in arteriovenous fistula (AVF), sponsored by Albany Medical College. Planned start Nov 2018; status: withdrawn.
02
Drugs
atorvastatin
03
Conditions
arteriovenous fistula (AVF)
Beyond the preview
Go deeper on NCT03188978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03188978.